Chris Blackwell, the chief executive of Chippenham-based drug development firm Vectura, is to step down after 12 years in the job. Dr Blackwell, pictured, joined the firm before its Initial Public Offering (IPO) and has led the company to its current position as a leader in the treatment of airways diseases. The firm,...